Drugs / IBP-9414
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT02472769 Comparator | May 2016 → Aug 2017 | necrotizing enterocolitis | Infant Bacterial Therapeutics | Completed | No outcome recorded |
| Phase 3 | NCT03978000 Comparator | Jul 2019 → Jun 2024 overdue | necrotizing enterocolitis | Infant Bacterial Therapeutics | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IBP-9414 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02472769 ↗ |
| Route | Oral | “IBP-9414 Oral Daily” NCT02472769 ↗ |